|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Smyth EC, Nilsson M, Grabsch HI, van
Grieken NC and Lordick F: Gastric cancer. Lancet. 396:635–648.
2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Johnston FM and Beckman M: Updates on
management of gastric cancer. Curr Oncol Rep. 21(67)2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wang FH, Zhang XT, Li YF, Tang L, Qu XJ,
Ying JE, Zhang J, Sun LY, Lin RB, Qiu H, et al: The Chinese society
of clinical oncology (CSCO): Clinical guidelines for the diagnosis
and treatment of gastric cancer, 2021. Cancer Commun (Lond).
41:747–795. 2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Simarro M, Gimenez-Cassina A, Kedersha N,
Lazaro JB, Adelmant GO, Marto JA, Rhee K, Tisdale S, Danial N,
Benarafa C, et al: Fast kinase domain-containing protein 3 is a
mitochondrial protein essential for cellular respiration. Biochem
Biophys Res Commun. 401:440–466. 2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Boehm E, Zaganelli S, Maundrell K,
Jourdain AA, Thore S and Martinou JC: FASTKD1 and FASTKD4 have
opposite effects on expression of specific mitochondrial RNAs,
depending upon their endonuclease-like RAP domain. Nucleic Acids
Res. 45:6135–6146. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jourdain AA, Koppen M, Rodley CD,
Maundrell K, Gueguen N, Reynier P, Guaras AM, Enriquez JA, Anderson
P, Simarro M and Martinou JC: A mitochondria-specific isoform of
FASTK is present in mitochondrial RNA granules and regulates gene
expression and function. Cell Rep. 10:1110–1121. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Jourdain AA, Popow J, de la Fuente MA,
Martinou JC, Anderson P and Simarro M: The FASTK family of
proteins: Emerging regulators of mitochondrial RNA biology. Nucleic
Acids Res. 45:10941–10947. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Colas E, Perez C, Cabrera S, Pedrola N,
Monge M, Castellvi J, Eyzaguirre F, Gregorio J, Ruiz A, Llaurado M,
et al: Molecular markers of endometrial carcinoma detected in
uterine aspirates. Int J Cancer. 129:2435–2444. 2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wang J, Mi JQ, Debernardi A, Vitte AL,
Emadali A, Meyer JA, Charmpi K, Ycart B, Callanan MB, Carroll WL,
et al: A six gene expression signature defines aggressive subtypes
and predicts outcome in childhood and adult acute lymphoblastic
leukemia. Oncotarget. 6:16527–16542. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Vivian J, Rao AA, Nothaft FA, Ketchum C,
Armstrong J, Novak A, Pfeil J, Narkizian J, Deran AD,
Musselman-Brown A, et al: Toil enables reproducible, open source,
big biomedical data analyses. Nat Biotechnol. 35:314–316.
2017.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Park SJ, Yoon BH, Kim SK and Kim SY:
GENT2: An updated gene expression database for normal and tumor
tissues. BMC Med Genomics. 12 (Suppl 5)(S101)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tomczak K, Czerwińska P and Wiznerowicz M:
The cancer genome atlas (TCGA): An immeasurable source of
knowledge. Contemp Oncol (Pozn). 19:A68–A77. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Cui J, Chen Y, Chou WC, Sun L, Chen L, Suo
J, Ni Z, Zhang M, Kong X, Hoffman LL, et al: An integrated
transcriptomic and computational analysis for biomarker
identification in gastric cancer. Nucleic Acids Res. 39:1197–1207.
2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Li WQ, Hu N, Burton VH, Yang HH, Su H,
Conway CM, Wang L, Wang C, Ding T, Xu Y, et al: PLCE1 mRNA and
protein expression and survival of patients with esophageal
squamous cell carcinoma and gastric adenocarcinoma. Cancer
Epidemiol Biomarkers Prev. 23:1579–1588. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Cheng L, Wang P, Yang S, Yang Y and Zhang
Q, Zhang W, Xiao H, Gao H and Zhang Q: Identification of genes with
a correlation between copy number and expression in gastric cancer.
BMC Med Genomics. 5(14)2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhang X, Ni Z, Duan Z, Xin Z, Wang H, Tan
J, Wang G and Li F: Overexpression of E2F mRNAs associated with
gastric cancer progression identified by the transcription factor
and miRNA co-regulatory network analysis. PLoS One.
10(e0116979)2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kim HK, Choi IJ, Kim CG, Kim HS, Oshima A,
Michalowski A and Green JE: A gene expression signature of acquired
chemoresistance to cisplatin and fluorouracil combination
chemotherapy in gastric cancer patients. PLoS One.
6(e16694)2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ooi CH, Ivanova T, Wu J, Lee M, Tan IB,
Tao J, Ward L, Koo JH, Gopalakrishnan V, Zhu Y, et al: Oncogenic
pathway combinations predict clinical prognosis in gastric cancer.
PLoS Genet. 5(e1000676)2009.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Förster S, Gretschel S, Jöns T, Yashiro M
and Kemmner W: THBS4, a novel stromal molecule of diffuse-type
gastric adenocarcinomas, identified by transcriptome-wide
expression profiling. Mod Pathol. 24:1390–1403. 2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wang G, Hu N, Yang HH, Wang L, Su H, Wang
C, Clifford R, Dawsey EM, Li JM, Ding T, et al: Comparison of
global gene expression of gastric cardia and noncardia cancers from
a high-risk population in China. PLoS One. 8(e63826)2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Busuttil RA, George J, Tothill RW,
Ioculano K, Kowalczyk A, Mitchell C, Lade S, Tan P, Haviv I and
Boussioutas A: A signature predicting poor prognosis in gastric and
ovarian cancer represents a coordinated macrophage and stromal
response. Clin Cancer Res. 20:2761–2772. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Vasaikar SV, Straub P, Wang J and Zhang B:
LinkedOmics: Analyzing multi-omics data within and across 32 cancer
types. Nucleic Acids Res. 46 (D1):D956–D963. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Team RC. R: A language and environment for
statistical computing. MSOR MSOR connections, pp1, 2014.
|
|
26
|
Love MI, Huber W and Anders S: Moderated
estimation of fold change and dispersion for RNA-seq data with
DESeq2. Genome Biol. 15(550)2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li T, Fan J, Wang B, Traugh N, Chen Q, Liu
JS, Li B and Liu XS: TIMER: A web server for comprehensive analysis
of tumor-infiltrating immune cells. Cancer Res. 77:e108–e110.
2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hänzelmann S, Castelo R and Guinney J:
GSVA: Gene set variation analysis for microarray and RNA-seq data.
BMC Bioinformatics. 14(7)2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhang B, Wu Q, Li B, Wang D, Wang L and
Zhou YL: m6A regulator-mediated methylation modification
patterns and tumor microenvironment infiltration characterization
in gastric cancer. Mol Cancer. 19(53)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Lánczky A and Győrffy B: Web-based
survival analysis tool tailored for medical research (KMplot):
Development and implementation. J Med Internet Res.
23(e27633)2021.PubMed/NCBI View
Article : Google Scholar
|
|
32
|
An Y and Duan H: The role of m6A RNA
methylation in cancer metabolism. Mol Cancer. 21(14)2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Liu C, Yang Z, Li R, Wu Y, Chi M, Gao S,
Sun X, Meng X and Wang B: Potential roles of N6-methyladenosine
(m6A) in immune cells. J Transl Med. 19(251)2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Chen X, Gong W, Shao X, Shi T, Zhang L,
Dong J, Shi Y, Shen S, Qin J, Jiang Q and Guo B: METTL3-mediated
m6A modification of ATG7 regulates autophagy-GATA4 axis
to promote cellular senescence and osteoarthritis progression. Ann
Rheum Dis. 81:87–99. 2022.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Marshall KD, Klutho PJ, Song L, Krenz M
and Baines CP: The novel cyclophilin-D-interacting protein FASTKD1
protects cells against oxidative stress-induced cell death. Am J
Physiol Cell Physiol. 317:C584–C599. 2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ramasubramanian A, Paramasivam A and
Ramani P: FASTK family of genes linked to cancer. Bioinformation.
18:206–213. 2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Nevins JR: Cell cycle targets of the DNA
tumor viruses. Curr Opin Genet Dev. 4:130–134. 1994.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Valimehr S, Sethi A, Shukla M,
Bhattacharyya S, Kazemi M and Rouiller I: Molecular mechanisms
driving and regulating the AAA+ ATPase VCP/p97, an important
therapeutic target for treating cancer, neurological and infectious
diseases. Biomolecules. 13(737)2023.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Sciarrillo R, Wojtuszkiewicz A, Assaraf
YG, Jansen G, Kaspers GJL, Giovannetti E and Cloos J: The role of
alternative splicing in cancer: From oncogenesis to drug
resistance. Drug Resist Updat. 53(100728)2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Church AJ, Akkari Y, Deeb K, Kolhe R, Lin
F, Spiteri E, Wolff DJ and Shao L: ACMG Laboratory Quality
Assurance Committee. Electronic address: documents@acmg.net.
Section E6.7-6.12 of the American college of medical genetics and
genomics (ACMG) technical laboratory standards: Cytogenomic studies
of acquired chromosomal abnormalities in solid tumors. Genet Med.
26(101070)2024.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Klaasen SJ, Truong MA, van Jaarsveld RH,
Koprivec I, Štimac V, de Vries SG, Risteski P, Kodba S, Vukušić K,
de Luca KL, et al: Nuclear chromosome locations dictate segregation
error frequencies. Nature. 607:604–609. 2022.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Wang M, Sunkel BD, Ray WC and Stanton BZ:
Chromatin structure in cancer. BMC Mol Cell Biol.
23(35)2022.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Barbieri I and Kouzarides T: Role of RNA
modifications in cancer. Nat Rev Cancer. 20:303–322.
2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Chang HHY, Pannunzio NR, Adachi N and
Lieber MR: Non-homologous DNA end joining and alternative pathways
to double-strand break repair. Nat Rev Mol Cell Biol. 18:495–506.
2017.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Sun Y, Liu Y, Ma X and Hu H: The influence
of cell cycle regulation on chemotherapy. Int J Mol Sci.
22(6923)2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Bowling EA, Wang JH, Gong F, Wu W, Neill
NJ, Kim IS, Tyagi S, Orellana M, Kurley SJ, Dominguez-Vidaña R, et
al: Spliceosome-targeted therapies trigger an antiviral immune
response in triple-negative breast cancer. Cell. 184:384–403.e21.
2021.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Dimaras H, Corson TW, Cobrinik D, White A,
Zhao J, Munier FL, Abramson DH, Shields CL, Chantada GL, Njuguna F
and Gallie BL: Retinoblastoma. Nat Rev Dis Primers.
1(15021)2015.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Ma M, Rodriguez A and Sugimoto K:
Activation of ATR-related protein kinase upon DNA damage
recognition. Curr Genet. 66:327–333. 2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Yang H, Zhou C, Dhar A and Pavletich NP:
Mechanism of strand exchange from RecA-DNA synaptic and D-loop
structures. Nature. 586:801–806. 2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Iliaki S, Beyaert R and Afonina IS:
Polo-like kinase 1 (PLK1) signaling in cancer and beyond. Biochem
Pharmacol. 193(114747)2021.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Zelensky A, Kanaar R and Wyman C:
Mediators of homologous DNA pairing. Cold Spring Harb Perspect
Biol. 6(a016451)2014.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Kutay U, Jühlen R and Antonin W: Mitotic
disassembly and reassembly of nuclear pore complexes. Trends Cell
Biol. 31:1019–1033. 2021.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Chen Y, Jia K, Sun Y, Zhang C, Li Y, Zhang
L, Chen Z, Zhang J, Hu Y, Yuan J, et al: Predicting response to
immunotherapy in gastric cancer via multi-dimensional analyses of
the tumour immune microenvironment. Nat Commun.
13(4851)2022.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Roy DM, Walsh LA, Desrichard A, Huse JT,
Wu W, Gao J, Bose P, Lee W and Chan TA: Integrated genomics for
pinpointing survival loci within arm-level somatic copy number
alterations. Cancer Cell. 29:737–750. 2016.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Truty R, Paul J, Kennemer M, Lincoln SE,
Olivares E, Nussbaum RL and Aradhya S: Prevalence and properties of
intragenic copy-number variation in Mendelian disease genes. Genet
Med. 21:114–123. 2019.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Dong X, Liu B, Yang L, Wang H, Wu B, Liu
R, Chen H, Chen X, Yu S, Chen B, et al: Clinical exome sequencing
as the first-tier test for diagnosing developmental disorders
covering both CNV and SNV: A Chinese cohort. J Med Genet.
57:558–566. 2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Gentile G, La Cognata V and Cavallaro S:
The contribution of CNVs to the most common aging-related
neurodegenerative diseases. Aging Clin Exp Res. 33:1187–1195.
2021.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Malhotra D and Sebat J: CNVs: Harbingers
of a rare variant revolution in psychiatric genetics. Cell.
148:1223–1241. 2012.PubMed/NCBI View Article : Google Scholar
|
|
59
|
DeVries AA, Dennis J, Tyrer JP, Peng PC,
Coetzee SG, Reyes AL, Plummer JT, Davis BD, Chen SS, Dezem FS, et
al: Copy number variants are ovarian cancer risk alleles at known
and novel risk loci. J Natl Cancer Inst. 114:1533–1544.
2022.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Xia Y, Rao L, Yao H, Wang Z, Ning P and
Chen X: Engineering macrophages for cancer immunotherapy and drug
delivery. Adv Mater. 32(e2002054)2020.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Chen L, Gao Y, Xu S, Yuan J, Wang M, Li T
and Gong J: N6-methyladenosine reader YTHDF family in biological
processes: Structures, roles, and mechanisms. Front Immunol.
14(1162607)2023.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Liu L, Li H, Hu D, Wang Y, Shao W, Zhong
J, Yang S, Liu J and Zhang J: Insights into N6-methyladenosine and
programmed cell death in cancer. Mol Cancer. 21(32)2022.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Wu Y, Wang Z, Shen J, Yan W, Xiang S, Liu
H and Huang W: The role of m6A methylation in osteosarcoma
biological processes and its potential clinical value. Hum
Genomics. 16(12)2022.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Hu J, Qiu D, Yu A, Hu J, Deng H, Li H, Yi
Z, Chen J and Zu X: YTHDF1 is a potential pan-cancer biomarker for
prognosis and immunotherapy. Front Oncol. 11(607224)2021.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Wei WS, Wang N, Deng MH, Dong P, Liu JY,
Xiang Z, Li XD, Li ZY, Liu ZH, Peng YL, et al: LRPPRC regulates
redox homeostasis via the circANKHD1/FOXM1 axis to enhance bladder
urothelial carcinoma tumorigenesis. Redox Biol.
48(102201)2021.PubMed/NCBI View Article : Google Scholar : (Epub ahead of
print).
|
|
66
|
Cui J, Wang L, Ren X, Zhang Y and Zhang H:
LRPPRC: A multifunctional protein involved in energy metabolism and
human disease. Front Physiol. 10(595)2019.PubMed/NCBI View Article : Google Scholar
|
